Artificial intelligence in heart valve disease: diagnosis, innovation and treatment. A state-of-the-art review.

The British journal of cardiology Pub Date : 2024-08-06 eCollection Date: 2024-01-01 DOI:10.5837/bjc.2024.031
Paul Bamford, Amr Abdelrahman, Christopher J Malkin, Michael S Cunnington, Daniel J Blackman, Noman Ali
{"title":"Artificial intelligence in heart valve disease: diagnosis, innovation and treatment. A state-of-the-art review.","authors":"Paul Bamford, Amr Abdelrahman, Christopher J Malkin, Michael S Cunnington, Daniel J Blackman, Noman Ali","doi":"10.5837/bjc.2024.031","DOIUrl":null,"url":null,"abstract":"<p><p>In recent years, artificial intelligence (AI) has been used to improve the precision of valvular heart disease diagnosis and treatment. It has the ability to identify and risk stratify patients with valvular heart disease and holds promise in improving the innovation of new treatments through shorter, safer and more effective clinical trials. AI can help to guide the treatment of patients with valvular heart disease, by aiding in optimal device selection for transcatheter valvular interventions and, potentially, predicting the risk of specific complications. This review article explores the various potential applications of AI in the diagnosis and treatment of valvular heart disease in more detail.</p>","PeriodicalId":74959,"journal":{"name":"The British journal of cardiology","volume":"31 3","pages":"031"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795922/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The British journal of cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5837/bjc.2024.031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In recent years, artificial intelligence (AI) has been used to improve the precision of valvular heart disease diagnosis and treatment. It has the ability to identify and risk stratify patients with valvular heart disease and holds promise in improving the innovation of new treatments through shorter, safer and more effective clinical trials. AI can help to guide the treatment of patients with valvular heart disease, by aiding in optimal device selection for transcatheter valvular interventions and, potentially, predicting the risk of specific complications. This review article explores the various potential applications of AI in the diagnosis and treatment of valvular heart disease in more detail.

人工智能在心脏瓣膜疾病中的应用:诊断、创新和治疗。最先进的评论。
近年来,人工智能(AI)已被用于提高瓣膜性心脏病的诊断和治疗精度。它有能力对瓣膜性心脏病患者进行识别和风险分层,并有望通过更短、更安全、更有效的临床试验,促进新疗法的创新。人工智能可以帮助指导瓣膜性心脏病患者的治疗,通过帮助选择经导管瓣膜干预的最佳设备,并潜在地预测特定并发症的风险。本文将详细探讨人工智能在瓣膜性心脏病诊断和治疗中的各种潜在应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信